vimarsana.com

Latest Breaking News On - Pharmaceuticals limited the company - Page 1 : vimarsana.com

ASLAN Pharmaceuticals : receives US$12,000,000 from Zenyaku Kogyo

ASLAN Pharmaceuticals receives US$12,000,000 from Zenyaku Kogyo On July 20, 2023, ASLAN Pharmaceuticals Limited announced that it had received the sum of US$12,000,000 from.

Zenyaku kogyoCompany us securitiesZenyaku holdings co ltdCompany annual report on formCompany registration statement on formExchange commissionExchange commission onPharmaceuticals limited the companyZenyaku kogyo co ltdCommission file noRegistration statementStrategic licensing agreementCommission fileAnnual report

ASLAN Pharmaceuticals : Second Quarter 2023 Cash Update

Second Quarter 2023 Cash Update Based on current estimates, as of June 30, 2023, ASLAN Pharmaceuticals Limited had cash and cash equivalents of $40.9 million..

Pharmaceuticals limited the companyZenyaku kogyo co ltdAmerican depositary shares of the company adssCompany registration statement on formExchange commissionZenyaku holdings co ltdWalkers singapore limited liability partnershipSecond quarterOpen market saleAmerican depositary sharesSecurities actProspectus supplementLimited liability partnershipSale agreementRegistration statement

ASLAN Pharmaceuticals : Amendment to Loan Agreement with K2 HealthVentures LLC

Amendment to Loan Agreementwith K2 HealthVentures LLC As previously disclosed in the Form 6-K filed with the Securities and Exchange Commission on July 14, 2021.

United statesPharmaceuticals pteHealthventures equity trustPharmaceuticals united states incSloan partyAnkura trust companyExchange commissionPharmaceuticals limited the companyCompany registration statement on formSecurity agreementLoan agreementLoan partiesFirst amendmentPrior reportVentures equity trustWarrant price

ASLAN Pharmaceuticals : Company Presentation May 2023

Company presentation May 2023 NASDAQ: ASLN 1 . | May 31, 2023

Drug administrationPharmaceuticals limited the companyCompany formCommission file noCompany us securitiesExchange commissionCommission fileAslan pharmaceuticals limited stock exchangePress releaseAy asln us04522r2004

ASLAN Pharmaceuticals : Company Presentation March 2023

Company presentation March 2023 NASDAQ: ASLN Legal disclaimer This. | March 30, 2023

Pharmaceuticals limited the companyDecision resources groupCompany formDrug administrationCommission file noExchange commissionCompany us securitiesCommission fileResources groupAslan pharmaceuticals limited stock exchangePress releaseEgal asln us04522r2004

vimarsana © 2020. All Rights Reserved.